Actively Recruiting
Study on Urinary Biomarkers and Bladder Imaging in Patients with Spina Bifida to Predict Kidney and Urinary Tract Damage
Led by Rennes University Hospital · Updated on 2025-12-22
50
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating urinary biomarkers to see if they can predict damage to the upper urinary tract and kidneys in patients with spina bifida. This study focuses on the biomarkers TIMP-2 and MMP-2, which may be linked to kidney degradation but have not yet been proven. The risk of upper urinary tract damage will be assessed using the Galloway score, which is based on urodynamic studies and retrograde urethrocystography performed regularly on these patients. Participants will have their urinary biomarkers measured at the time of their routine urodynamic assessment. The study includes collection of urine samples at inclusion and after one year to analyze biomarkers and metabolomics. A subset of adult patients will also undergo Magnetic Resonance Imaging MRI of the bladder at inclusion and after one year to assess bladder conditions through radiomic markers. During the study, participants will be monitored for the association between urinary biomarker levels and the Galloway score. Researchers will track treatment success or failure over one year and evaluate bladder hypocompliance through metabolomic profiles and MRI markers. The presence of biomarkers in bladder tissue will also be examined from enrollment through one year. The total participation involves assessments at inclusion and at one year with monitoring of clinical and imaging outcomes.
CONDITIONS
Brief Title
Evaluation of muLtimodal and Non-invasive SPINa Bifida Neurovessels During Prospective Follow-up
Research Team
L
LOÏC JACOB
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here